fbpx

R+D+I: Kliniske Studier ved Instituto Bernabeu

Prolutex in Frozen Embryo Transfer Cycles at the Blastocyst Stage (PROGEX) NCT03701490

Prolutex in Frozen Embryo Transfer Cycles at the Blastocyst Stage (PROGEX) NCT03701490

What is studied: It is the first clinical trial in the world to use Progesterone administered subcutaneously at a dose of 50 mg daily and compares it with standard vaginal administration.

Aim: We want to know the optimal treatment protocol that can improve the results through the administration route of the medication of patients who receive frozen embryos. 

Start: March 2020

Location: Instituto Bernabeu Alicante

More information: For more information click here

For study details you can find them through the link

La oss snakke

Vi anbefaler deg uten forpliktelser